Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 4/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 4/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9787852 | 1.00 | LPL (0.33) | LPLLIPGKCNH2KDM4EPDE3B | |
| SCHEMBL9788005 | 1.00 | LPL (0.33) | LPLLIPGKCNH2KDM4EPDE3B | |
| SCHEMBL10619634 | 1.00 | LPL (0.33) | LPLLIPGKCNH2KDM4EPDE3B | |
| SCHEMBL10616726 | 1.00 | LPL (0.33) | LPLLIPGKCNH2KDM4EPDE3B | |
| SCHEMBL9787882 | 1.00 | LPL (0.33) | LPLLIPGKCNH2KDM4EPDE3B | |
| SCHEMBL10491866 | 1.00 | LPL (0.33) | LPLLIPGKCNH2KDM4EPDE3B | |
| SCHEMBL9787850 | 1.00 | LPL (0.33) | LPLLIPGKCNH2KDM4EPDE3B | |
| SCHEMBL10491816 | 1.00 | LPL (0.33) | LPLLIPGKCNH2KDM4EPDE3B | |
| SCHEMBL9787963 | 0.98 | KDM4E (0.34) | LPLLIPGKCNH2KDM4E | |
| SCHEMBL5796273 | 0.92 | KDM4E (0.35) | KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12544361-B2 | Composition comprising at least one oxazoline for inhibiting the growth of Malassezia yeasts involved in cradle cap, in particular | LABORATOIRES EXPANSCIENCE (FR) | 2026-02-10 | — | — | US | claimed |
| US-20220249446-A1 | Composition Comprising at Least One Oxazoline for Inhibiting the Growth of Malassezia Yeasts Involved in Cradle Cap, in Particular | LABORATOIRES EXPANSCIENCE (FR) | 2022-08-11 | — | — | US | claimed |
| EP-3996674-A1 | COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE FOR INHIBITING THE GROWTH OF MALASSEZIA YEASTS INVOLVED IN CRADLE CAP, IN PARTICULAR | Laboratoires Expanscience (FR) | 2022-05-18 | — | — | EP | claimed |
| EP-2953611-B1 | USE OF A COMPOSITION COMPRISING AVOCADO PERSEOSE IN THE PROTECTION OF EPIDERMAL STEM CELLS | EXPANSCIENCE LAB (FR) | 2021-08-18 | — | — | EP | claimed |
| WO-2021009142-A1 | COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE FOR INHIBITING THE GROWTH OF MALASSEZIA YEASTS INVOLVED IN CRADLE CAP, IN PARTICULAR | LABORATOIRES EXPANSCIENCE (FR) | 2021-01-21 | — | — | WO | claimed |
| US-20200085897-A1 | Extract of Aerial Parts of Maca Rich in Polyphenols and Composition Comprising Same | LABORATOIRES EXPANSCIENCE (FR) | 2020-03-19 | — | — | US | claimed |
| EP-2654765-B1 | EXTRACT OF THE AERIAL PARTS OF MACA RICH IN POLYPHENOL AND COMPOSITION COMPRISING THE EXTRACT | EXPANSCIENCE LAB (FR) | 2019-03-13 | — | — | EP | claimed |
| EP-2654766-B1 | EXTRACT OF THE PULP AND/OR PEEL OF AVOCADO RICH IN POLYPHENOLS AND COSMETIC, DERMATOLOGIC OR NUTRACEUTIC COMPOSITIONS COMPRISING THEREOF | EXPANSCIENCE LAB (FR) | 2018-10-10 | — | — | EP | claimed |
| EP-2654762-B1 | EXTRACT OF THE AERIAL PARTS OF GYNANDROPSIS GYNANDRA AND COSMETIC, DERMATOLIGIC AND PHARMACEUTIC COMPOSITIONS COMPRISING THE EXTRACT | EXPANSCIENCE LAB (FR) | 2018-09-26 | — | — | EP | claimed |
| US-9616009-B2 | Composition containing at least one C7 sugar for alopecia treatment, cosmetic treatment of hair and nails, and care of hair, eyelashes or nails | LABORATOIRES EXPANSCIENCE (FR) | 2017-04-11 | — | — | US | claimed |
| WO-2004112741-A1 | COSMETIC USE OF A COMPOSITION CONTAINING AT LEAST ONE OXAZOLINE, SERVING AS AN ACTIVE SUBSTANCE, AS A SLIMMING PRODUCT AND/OR FOR PREVENTING AND/OR TREATING CELLULITE | LABORATOIRES EXPANSCIENCE (FR) | 2004-12-29 | — | — | WO | claimed |
| EP-1458349-A1 | COMPOSITION COMPRISING AT LEAST AN OXAZOLIN FOR INHIBITING LANGERHANS CELL MIGRATION, AND USES THEREOF | Laboratoires Expanscience (FR) | 2004-09-22 | — | — | EP | claimed |
| WO-2003055463-A1 | COMPOSITION COMPRISING AT LEAST AN OXAZOLIN FOR INHIBITING LANGERHANS CELL MIGRATION, AND USES THEREOF | LABORATOIRES EXPANSCIENCE (FR) | 2003-07-10 | — | — | WO | claimed |
| EP-0260339-B1 | OXAZOLINE/POLYOL/POLYISOCYANATE POLYMERS AND PROCESS | Ashland Oil, Inc. (US) | 1991-03-13 | — | — | EP | claimed |
| US-4876249-A | TOPICAL; TRANSDERMAL, SYSTEMIC; FLUOCINOLINE ACETONIDE AND IMIDAZOLINE OR OXAZOLINE PENETRATION ENHANCER MIXTURE; THERAPEUTIC DRUGS | THERAPEUTIC PATCH RESEARCH N.V. | 1989-10-24 | — | — | US | claimed |
| EP-0296199-A1 | HETEROCYCLIC COMPOUNDS FOR TRANSDERMAL USE | RAJADHYAKSHA, Vithal J. (US) | 1988-12-28 | — | — | EP | claimed |
| WO-1988004938-A1 | HETEROCYCLIC COMPOUNDS FOR TRANSDERMAL USE | RAJADHYAKSHA VITHAL J (US) | 1988-07-14 | — | — | WO | claimed |
| EP-0260339-A1 | Oxazoline/polyol/polyisocyanate polymers and process | Ashland Oil, Inc. (US) | 1988-03-23 | — | — | EP | claimed |
| US-4640969-A | IMPROVED IMPACT STRENGHT | ASHLAND OIL, INC. (US) | 1987-02-03 | — | — | US | claimed |
| US-4558114-A | INCREASING REACTION RATES | ASHLAND OIL, INC. (US) | 1985-12-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12544361-B2 | Composition comprising at least one oxazoline for inhibiting the growth of Malassezia yeasts involved in cradle cap, in particular | HSD17B12, CYP51A1, OXGR1 | LPL 2826/4885LIPG 1713/4885KCNH2 4512/4885 |
| US-20220249446-A1 | Composition Comprising at Least One Oxazoline for Inhibiting the Growth of Malassezia Yeasts Involved in Cradle Cap, in Particular | OCIAD1, ERG28, CYP51A1 | LPL 3196/4885LIPG 1796/4885KCNH2 4055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.